Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00125060 · ClinicalTrials.gov registry record · NA
Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT00125060: Completed NA study, sponsored by Johns Hopkins University.
NCT00125060 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00125060, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
This research is being done to investigate the ability of an experimental imaging method - transesophageal magnetic resonance imaging (TEMRI), to detect the change in aortic atherosclerotic plaque burden and morphology between patients on high dose cholesterol lowering medications and patients on standard dose cholesterol lowering medications. This study will use TEMRI to see how atherosclerosis (cholesterol build up) changes with cholesterol lowering medications. This study will also investigate whether these cholesterol-lowering medications will change levels of blood tests, called inflammatory markers, in patients' blood. People with atherosclerosis may join this study. This study will also store blood samples for future studies of cardiac diseases; no gene testing will be done.
Interventions
- DRUG Simvastatin (20mg versus 80mg/day)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2000-08 |
| Est. Completion | 2004-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00125060
The ClinicalTrials.gov registry entry for NCT00125060 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Simvastatin (20mg versus 80mg/day) is the first listed.
NCT00125060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00125060 about?
NCT00125060 is a clinical study titled "Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures". This research is being done to investigate the ability of an experimental imaging method - transesophageal magnetic resonance imaging (TEMRI), to detect the change in aortic atherosclerotic plaque burden and morphology between patients on high dose cholesterol lowering medications and patients on st...
What is the current status of trial NCT00125060?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2000-08. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00125060?
The interventions under investigation include: Simvastatin (20mg versus 80mg/day) (DRUG).
Who is sponsoring clinical trial NCT00125060?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.